Intrinsic Value of S&P & Nasdaq Contact Us

Tenaya Therapeutics, Inc. TNYA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
66/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.33
+215.3%

Stock Statistics — TNYA

Tenaya Therapeutics, Inc. (TNYA) has a market capitalization of $123.12M and trades at $0.74. The 52-week range is 0.36-2.35.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-0.59.

The stock has a beta of 3.00, operates in the Healthcare sector.

Trading Data
Current Price$0.74
52-Week Range0.36-2.35
Volume2.75M
Avg Volume (30D)4.43M
Market Cap$123.12M
Beta (1Y)3.00
Company
IPO Date2021-07-30
Employees97
CEOFaraz Ali
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS87990A1060
CUSIP87990A106
Income (Latest Year)
Gross Profit$-8.44M
EBITDA$-84.9M
Operating Income$-93.33M
Net Income$-90.6M
EPS$-0.59
EPS Diluted$-0.59
Shares Outstanding$152.97M
Balance Sheet (Latest Year)
Total Assets$146.92M
Current Assets$105.59M
Cash & ST Investments$100.55M
Total Liabilities$23.66M
Total Debt$10.83M
Net Debt$-89.72M
Total Equity$123.27M
Debt / Equity0.09
Valuation Ratios
P/E Ratio-1.3
P/B Ratio1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message